Clinical trial
Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in…
NCT00317668 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00317668 |
|---|---|
| Title | Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Epilepsy |
| Enrollment | 250 |
| Start date | Nov 1, 2006 |
| First posted | Apr 25, 2006 |
| Last update posted | May 1, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: